Buxton O M, Copinschi G, Van Onderbergen A, Karrison T G, Van Cauter E
Department of Medicine, University of Chicago, Illinois 60637, USA.
Sleep. 2000 Nov 1;23(7):915-27.
To determine whether appropriately timed administration of a short-acting benzodiazepine hypnotic, which has proven effective in an animal model of jet lag, also facilitates adaptation of circadian rhythmicity and sleep-wake homeostasis in a human model of jet lag.
Subjects participated in two double-blind, placebo-controlled studies of adaptation to an 8-hr delay shift of sleep-wake and dark-light cycles simulating westward travel. Each 9-day laboratory study began with a 3-day habituation period followed by a 24-hr study to obtain basal hormonal and sleep profiles (23:00-07:00). Subjects were then kept awake until 07:00 the next day and slept in darkness 07:00-15:00 for the next five 24-hr spans post-shift.
N/A.
6 normal, healthy men 24-31 years of age.
Oral Triazolam (0.5 mg) or placebo given at 04:00 before the first shifted sleep/dark period (3 hours before bedtime) and at 07:00 (at bedtime) on days 2-5 post-shift.
Sleep recordings and 24-hr cortisol and growth hormone profiles were obtained at baseline and on the first, third, and fifth days post-shift. Global measures of treatment efficacy were calculated for multiple endpoints representing circadian rhythmicity and sleep-wake homeostasis. With placebo, the shift induced disturbances of sleep and hormonal secretion, and a gradual re-entrainment of circadian rhythmicity. Triazolam significantly facilitated adaptation by accelerating re-entrainment of circadian rhythms (chronobiotic effect) and normalizing markers of sleep/wake homeostasis (hypnotic effect).
Appropriately timed administration of a benzodiazepine hypnotic appears to facilitate the adaptation of both circadian rhythmicity and sleep-wake homeostasis to a shifted dark/sleep cycle. Compounds with combined chronobiotic/hypnotic properties may be useful in conditions of jet lag or night work.
确定在时差反应动物模型中已被证明有效的短效苯二氮䓬类催眠药在适当时间给药,是否也能促进人体时差反应模型中昼夜节律和睡眠-觉醒稳态的适应。
受试者参与了两项双盲、安慰剂对照研究,以适应模拟向西旅行的8小时睡眠-觉醒和明暗周期延迟。每项为期9天的实验室研究开始时有3天的适应期,随后是一项24小时研究,以获取基础激素和睡眠情况(23:00 - 07:00)。然后受试者保持清醒至第二天07:00,并在接下来的五个24小时时间段(时差转换后)于07:00 - 15:00在黑暗中睡眠。
无。
6名年龄在24 - 31岁之间的正常健康男性。
在第一个时差转换后的睡眠/黑暗期之前的04:00(就寝时间前3小时)以及时差转换后第2 - 5天的07:00(就寝时间)口服三唑仑(0.5毫克)或安慰剂。
在基线以及时差转换后的第一天、第三天和第五天获取睡眠记录以及24小时皮质醇和生长激素情况。针对代表昼夜节律和睡眠-觉醒稳态的多个终点计算治疗效果的总体测量值。使用安慰剂时,时差转换引发了睡眠和激素分泌紊乱,以及昼夜节律的逐渐重新调整。三唑仑通过加速昼夜节律的重新调整(生物钟效应)和使睡眠/觉醒稳态标志物正常化(催眠效应),显著促进了适应过程。
苯二氮䓬类催眠药在适当时间给药似乎有助于昼夜节律和睡眠-觉醒稳态适应明暗/睡眠周期的改变。具有生物钟/催眠复合特性的化合物可能对时差反应或夜间工作情况有用。